Pharmaceuticals & Biotech South African Community
Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
Pharmaceuticals & Biotech South African Investing Ideas
AN
Consensus Narrative from 5 Analysts
Commercial Pharma And GLP-1 Expansion Will Empower Future Progress
Key Takeaways Steady commercial pharma growth through strategic market focus in China and Russia enhances revenue stability. GLP-1 and insulin manufacturing expansion offers substantial long-term revenue and margin growth potential.
View narrativeR157.26
FV
22.6% undervalued intrinsic discount4.25%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
18users have followed this narrative
Updated narrative